| 3.115 0.015 (0.48%) | 10-24 15:02 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.35 | 1-year : | 8.3 |
| Resists | First : | 4.58 | Second : | 7.11 |
| Pivot price | 4.16  |
|||
| Supports | First : | 0.48 | Second : | 0.4 |
| MAs | MA(5) : | 3.09 |
MA(20) : | 4.49 |
| MA(100) : | 12.48 |
MA(250) : | 295.74 |
|
| MACD | MACD : | -1.2  |
Signal : | -1.2 |
| %K %D | K(14,3) : | 38.4 |
D(3) : | 38.7 |
| RSI | RSI(14): 30.1 |
|||
| 52-week | High : | 2198.4 | Low : | 0.48 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CDT ] has closed above bottom band by 27.4%. Bollinger Bands are 39.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.21 - 3.23 | 3.23 - 3.25 |
| Low: | 2.67 - 2.7 | 2.7 - 2.72 |
| Close: | 3.06 - 3.1 | 3.1 - 3.14 |
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Fri, 17 Oct 2025
CDT Equity acquires 9.25 bitcoin for $1 million - Investing.com
Fri, 17 Oct 2025
CDT Equity increases bitcoin holding - MSN
Fri, 17 Oct 2025
CDT Equity Inc. Acquires $1 Million in Bitcoin as Part of Cryptocurrency Treasury Reserve Strategy - Quiver Quantitative
Fri, 17 Oct 2025
Cdt Equity Inc buys 9.256 bitcoin for $1,005,000 - MarketScreener
Thu, 16 Oct 2025
US-listed company CDT Equity increases its holdings by approximately 9.25 bitcoins - Bitget
Thu, 09 Oct 2025
CDT Equity Inc. Announces Reverse Stock Split - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.06e+006 (%) |
| Held by Institutions | 66.3 (%) |
| Shares Short | 13 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -198.1 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 137.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -3.11 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 3.76 |
| Dividend | 0 |
| Forward Dividend | 21810 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|